The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them.  It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come.  

GARDP works through a global network including Brazil, India, Japan, and South Africa for antibiotic development and access. Its work is made possible by essential funding from donors and collaboration with over 100 R&D and access partners in over 20 countries.  

GARDP was created by the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi) in 2016 and legally registered as the GARDP Foundation in Geneva, Switzerland in 2018. 

 www.gardp.org  

Health Care

Life Sciences

Medical Devices

Pharmaceutical

Global Antibiotic R&D Partnership (GARDP)

Manica Balasegaram

Ravindra P. Jumde

Dianna Taylor

Alexandra Santu

Rashmi Mathur

Astrid Pentz - Murr

Erika Mendes Correia

Daniel Iniguez

Teri Roberts

Raji Devarajan

Karin Hergarden

Yann Ferrisse

Tammy Pillay

Pierre - Yves Delhez

Paul Sabatier

Jeffrey Rowland

Dominique De Santis

Carmen Au

Angela Decool

Alison Luckey

Ada Yonath

Clinical Operations Team

Scientific and Research Team

Communications

Finance and Accounting

Teams at Global Antibiotic R&D Partnership (GARDP)

Clinical Operations Team

Scientific and Research Team

Communications

Finance and Accounting